The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
B7-H1 Is Expressed by Human Endothelial Cells and Suppresses T Cell Cytokine Synthesis
Open accessAbstract
Human endothelial cells (ECs) provide costimulatory signals sufficient to activate resting memory T cells to produce IL-2 and IFN-γ, at least in part through CD58-CD2 interactions. Recently, the B7-like molecule, B7-H1 (PD-L1), was described and shown to regulate T cell activation; however, there are conflicting reports on whether it stimulates or inhibits T cell cytokine synthesis. B7-H1 is not expressed constitutively by ECs; however, it is rapidly induced by IFN-γ, and synergistically by IFN-γ and TNF. In inflamed skin, B7-H1 is expressed by a subset of microvessels, and by keratinocytes, but is barely detectable in normal skin. Blocking the interaction of EC-expressed B7-H1 with its T cell ligand, programmed death-1 (PD-1), using a PD-1-Fc fusion protein, or by blocking B7-H1 expression with morpholino antisense oligonucleotides, augments expression of IL-2 and IFN-γ, implicating B7-H1 as a negative regulator of cytokine synthesis. However, signaling through PD-1 does not affect induction of the activation markers CD25 or CD69 on T cells, suggesting that its effects are specific to cytokine synthesis. The suppressive effects of B7-H1 on cytokine expression are proportional to the strength of the primary stimulus, allowing for B7-H1 to determine the level of T cell activation in response to ECs. Our results demonstrate that B7-H1 negatively regulates cytokine synthesis in T cells activated by ECs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Freeman, G. J., Long, A. J., Iwai, Y., Bourque, K., Chernova, T., Nishimura, H., Fitz, L. J., Malenkovich, N., Okazaki, T., Byrne, M. C., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.7.1027 · Cited by 5,294
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
Latchman, Y., Wood, C. R., Chernova, T., Chaudhary, D., Borde, M., Chernova, I., Iwai, Y., Long, A. J., Brown, J. A., Nunes, R., et al. (2001) · Nature Immunology · doi:10.1038/85330 · Cited by 2,955
Nishimura, H., Nose, M., Hiai, H., Minato, N., & Honjo, T. (1999) · Immunity · doi:10.1016/s1074-7613(00)80089-8 · Cited by 2,749
Dong, H., Zhu, G., Tamada, K., & Chen, L. (1999) · Nature Medicine · doi:10.1038/70932 · Cited by 2,496
Autoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient Mice
Nishimura, H., Okazaki, T., Tanaka, Y., Nakatani, K., Hara, M., Matsumori, A., Sasayama, S., Mizoguchi, A., Hiai, H., Minato, N., et al. (2001) · Science · doi:10.1126/science.291.5502.319 · Cited by 1,868
The B7 and CD28 receptor families
June, C. H., Bluestone, J. A., Nadler, L. M., & Thompson, C. B. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90080-9 · Cited by 1,296
Meuer, S. C., Hussey, R. E., Fabbi, M., Fox, D., Acuto, O., Fitzgerald, K. A., Hodgdon, J. C., Protentis, J. P., Schlossman, S. F., & Reinherz, E. L. (1984) · Cell · doi:10.1016/0092-8674(84)90039-4 · Cited by 1,113
T Cell Activation Determined by T Cell Receptor Number and Tunable Thresholds
Viola, A., & Lanzavecchia, A. (1996) · Science · doi:10.1126/science.273.5271.104 · Cited by 1,023
B7-H3: A costimulatory molecule for T cell activation and IFN-γ production
Chapoval, A. I., Ni, J., Lau, J. S., Wilcox, R. A., Flies, D. B., Liu, D., Dong, H., Sica, G. L., Zhu, G., Tamada, K., et al. (2001) · Nature Immunology · doi:10.1038/85339 · Cited by 1,015
Okazaki, T., Maeda, A., Nishimura, H., Kurosaki, T., & Honjo, T. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231486598 · Cited by 848
Helper T Cell Differentiation Is Controlled by the Cell Cycle
Bird, J. J., Brown, D. R., Mullen, A. C., Moskowitz, N. H., Mahowald, M. A., Sider, J. R., Gajewski, T. F., Wang, C.-R., & Reiner, S. L. (1998) · Immunity · doi:10.1016/s1074-7613(00)80605-6 · Cited by 832
PD-1:PD-L inhibitory pathway affects both CD4+ and CD8+ T cells and is overcome by IL-2
Carter, L. L., Fouser, L. A., Jussif, J., Fitz, L., Deng, B., Wood, C. R., Collins, M., Honjo, T., Freeman, G. J., & Carreno, B. M. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200203)32:3<634::aid-immu634>3.0.co;2-9 · Cited by 673
PD-1: an inhibitory immunoreceptor involved in peripheral tolerance
Nishimura, H., & Honjo, T. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)01888-9 · Cited by 474
Karmann, K., Hughes, C. C., Schechner, J., Fanslow, W. C., & Pober, J. S. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4342 · Cited by 472
Self-citationCoyle, A. J., & Gutierrez-Ramos, J.-C. (2001) · Nature Immunology · doi:10.1038/85251 · Cited by 413
Flynn, S., Toellner, K.-M., Raykundalia, C., Goodall, M., & Lane, P. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.297 · Cited by 351
Functional Responses and Costimulator Dependence of Memory CD4+ T Cells
London, C. A., Lodge, M. P., & Abbas, A. K. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.1.265 · Cited by 314
Imura, A., Hori, T., Imada, K., Ishikawa, T., Tanaka, Y., Maeda, M., Imamura, S., & Uchiyama, T. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.5.2185 · Cited by 309
Expression and regulation of the PD-L1 immunoinhibitory molecule on microvascular endothelial cells
Eppihimer, M., Gunn, J., Freeman, G., Greenfield, E., Chernova, T., Erickson, J., & Leonard, J. (2002) · Microcirculation · doi:10.1080/713774061 · Cited by 272
Khayyamian, S., Hutloff, A., Büchner, K., Gräfe, M., Henn, V., Kroczek, R. A., & Mages, H. W. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092576699 · Cited by 236
The expanding world of co-stimulation: the two-signal model revisited
Chambers, C. A. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)01868-3 · Cited by 214
Itoh, Y., & Germain, R. N. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.5.757 · Cited by 213
Waldrop, S. L., Davis, K. A., Maino, V. C., & Picker, L. J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.10.5284 · Cited by 199
Petzelbauer, P., Bender, J. R., Wilson, J., & Pober, J. S. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.9.5062 · Cited by 187
CAN GRAFT ENDOTHELIAL CELLS INITIATE A HOST ANTI-GRAFT IMMUNE RESPONSE?1
Pober, J. S., Orosz, C. G., Rose, M. L., & Savage, C. O. S. (1996) · Transplantation · doi:10.1097/00007890-199602150-00001 · Cited by 157
Hughes, C. C., Savage, C. O. S., & Pober, J. S. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.171.5.1453 · Cited by 143
Self-citationMa, W., & Pober, J. S. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.5.2158 · Cited by 136
Marelli‐Berg, F. M., Hargreaves, R. E. G., Carmichael, P., Dorling, A., Lombardi, G., & Lechler, R. I. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.4.1603 · Cited by 122
Denton, M., Geehan, C. S., Alexander, S. I., Sayegh, M. H., & Briscoe, D. M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.4.555 · Cited by 119
HUMAN CD4+ T CELLS PROLIFERATE TO HLA-DR+ ALLOGENEIC VASCULAR ENDOTHELIUM
Savage, C. O. S., HUGHES, C. C. W., McIntyre, B. W., et al. (1993) · Transplantation · doi:10.1097/00007890-199307000-00024 · Cited by 110
Self-citationDengler, T. J., & Pober, J. S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.10.5146 · Cited by 102
Immunobiology of human vascular endothelium
Pober, J. S. (1999) · Immunologic Research · doi:10.1007/bf02786490 · Cited by 102
Endothelial cells as antigen-presenting cells: role in human transplant rejection
Rose, M. L. (1998) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050226 · Cited by 99
Interactions between T lymphocytes and endothelial cells in allograft rejection
Briscoe, D. M., Alexander, S. I., & Lichtman, A. H. (1998) · Current Opinion in Immunology · doi:10.1016/s0952-7915(98)80218-5 · Cited by 96
Sancho, D., Yáñez‐Mó, M., Tejedor, R., & Sánchez‐Madrid, F. (1999) · Blood · doi:10.1182/blood.v93.3.886 · Cited by 82
Savage, C. O. S., Hughes, C. C. W., Pepinsky, R. B., Wallner, B. P., Freedman, A. S., & Pober, J. S. (1991) · Cellular Immunology · doi:10.1016/0008-8749(91)90065-j · Cited by 61
Self-citationMestas, J., & Hughes, C. C. W. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.8.4378 · Cited by 50
Self-citationA Subtle Role for Cd2 in T Cell Antigen Recognition
van der Merwe, P. A. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.10.1371 · Cited by 32
Murphy, L. L. S., Mazanet, M. M., Taylor, A. C., Mestas, J., & Hughes, C. C. W. (1999) · Cellular Immunology · doi:10.1006/cimm.1999.1504 · Cited by 20
Self-citation
Cited by
PD-1 and Its Ligands in Tolerance and Immunity
Keir, M. E., Butte, M. J., Freeman, G. J., & Sharpe, A. H. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090331 · Cited by 5,378
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
Topalian, S. L., Taube, J. M., Anders, R. A., & Pardoll, D. M. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.36 · Cited by 2,733
Taube, J. M., Klein, A., Brahmer, J. R., Xu, H., Pan, X., Kim, J. H., Chen, L., Pardoll, D. M., Topalian, S. L., & Anders, R. A. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3271 · Cited by 2,324
Regulation and Function of the PD-L1 Checkpoint
Sun, C., Mezzadra, R., & Schumacher, T. N. (2018) · Immunity · doi:10.1016/j.immuni.2018.03.014 · Cited by 2,193
Inhibitory B7-family molecules in the tumour microenvironment
Zou, W., & Chen, L. (2008) · Nature Reviews Immunology · doi:10.1038/nri2326 · Cited by 1,608
Metadata
- Authors
- Mazanet, M. M., & Hughes, C. C. W.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-10-01
- Volume
- 169
- Issue
- 7
- Pages
- 3581-3588
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2138905083
- Cited by
- 326
- References
- 39
- FWCI
- 5.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.